Zobrazeno 1 - 10
of 238
pro vyhledávání: '"K A, Jørgensen"'
Autor:
D. Andreou, N. E. Steen, K. N. Jørgensen, T. Ueland, L. A. Wortinger, L. Mørch-Johnsen, R. H. Yolken, O. A. Andreassen, I. Agartz
Publikováno v:
European Psychiatry, Vol 67, Pp S47-S47 (2024)
Introduction Previous research has implicated herpes simplex virus 1 (HSV1) and cytomegalovirus (CMV) in severe mental illness (SMI) with conflicting results. Both pathogens have high universal seroprevalence, are neurotropic and after the primary in
Externí odkaz:
https://doaj.org/article/636babea04e24ddca95a6e36f91abac5
Publikováno v:
European Psychiatry, Vol 66, Pp S107-S107 (2023)
Introduction Postnatal cytomegalovirus (CMV) infection of immunocompetent hosts is usually inapparent but typically results in lifelong latency. Congenital CMV infections as well as CMV infections in patients with immunodeficiencies have been linked
Externí odkaz:
https://doaj.org/article/a11c57abc75a45748b6ca71884dad674
Autor:
T. Calkova, L. Mørch-Johnsen, R. Elle Smelror, K. Nordbø Jørgensen, S. Cervenka, K. Collste, A. Vaskinn, A. Margrethe Myhre, O. A. Andreassen, T. Ueland, I. Agartz, D. Andreou
Publikováno v:
European Psychiatry, Vol 66, Pp S490-S491 (2023)
Introduction Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with w
Externí odkaz:
https://doaj.org/article/9b7a1d0df8304b08810a67e429880c46
Publikováno v:
Mcleod, D, Izzo, J A, Jørgensen, D K B, Lauridsen, R F & Jørgensen, K A 2020, ' Development and Investigation of an Organocatalytic Enantioselective [10 + 2] Cycloaddition ', ACS Catalysis, vol. 10, no. 18, pp. 10784-10793 . https://doi.org/10.1021/acscatal.0c03378
A stereoselective [10 + 2] cycloaddition for the reaction of homologated indenecarbaldehydes with α,β-unsaturated aldehydes, providing tetrahydrocyclopenta[a]indenes, has been developed and investigated mechanistically. The reaction proceeds via an
Autor:
I. Egeland Christensen, I. Jyssum, A. T. Tveter, J. Sexton, T. T. Tran, S. Mjaaland, G. B. Kro, T. K. Kvien, D. Worren, J. Jahnsen, L. A. Munthe, E. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, K. K. Jørgensen, S. W. Syversen, G. L. Goll, S. Aarrestad Provan
Publikováno v:
Annals of the Rheumatic Diseases. 81:116-117
BackgroundLimited data is available regarding long-term effectiveness of SARS-CoV-2 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy. Whether the persistence of vaccine-induced humoral immunity agai
Autor:
K Bjørlykke, M K Brun, M K Viken, G E Stenvik, R A Klaasen, J E Gehin, D J Warren, J Sexton, E A Haavardsholm, J Jahnsen, B A Lie, G L Goll, N Bolstad, S W Syversen, K K Jørgensen
Publikováno v:
Journal of Crohn's and Colitis. 16:i594-i595
Background Immunogenicity is a leading cause of treatment failure to TNF inhibitors. Genetic variations in HLA class II genes have been suggested to predispose to anti-drug antibody formation, but studies using high-resolution HLA typing as well as c
Autor:
E. K. Strand, I. S. H. Hatten, Kathrine A. Seeberg, Knut E.A. Lundin, Rolf Anton Klaasen, Tore K Kvien, Knut Tveit, C. Mørk, Espen A Haavardsholm, S. S. Hoie, G. L. Goll, Gert Huppertz-Hauss, Jon Hagfors, A. Poyan, Synøve Kalstad, B. Gulbrandsen, Geir Noraberg, Jørgen Jahnsen, David J. Warren, K. Waksvik, K. Ryggen, H. U. Rashid, Cecilia Vold, Ingrid Prytz Berset, Øivind Asak, Nils Bolstad, S. O. Frigstad, Bjørg Tilde Svanes Fevang, Bjørn Moum, Ulf Prestegård, Joseph Sexton, C. C. Zettel, I. P. Midtgard, Magne Henriksen, Ingrid M. Blomgren, M. Lorentzen, Roald Torp, Carl Magnus Ystrøm, K. Skjetne, T. J. Bruun, Katrine Dvergsnes, Pawel Mielnik, J. Krogh, Ø. Brenna, Inge C. Olsen, Inger Marie Jensen Hansen, S. Baigh, K. K. Jørgensen
Publikováno v:
Journal of Internal Medicine
BACKGROUND AND OBJECTIVES: The 52-week, randomized, double-blind, noninferiority, government-funded NOR-SWITCH trial demonstrated that switching from infliximab originator to less expensive biosimilar CT-P13 was not inferior to continued treatment wi
Autor:
M. K. Brun, K. H. Bjørlykke, M. K. Viken, B. Stenvik, R. A. Klaasen, J. Gehin, D. J. Warren, J. Sexton, Ø. Sandanger, C. Mørk, T. K. Kvien, E. A. Haavardsholm, J. Jahnsen, G. L. Goll, B. A. Lie, K. K. Jørgensen, N. Bolstad, S. W. Syversen
Publikováno v:
Annals of the Rheumatic Diseases. 81:216.2-217
BackgroundImmunogenicity is a leading cause of treatment failure to TNF inhibitors, and also affects drug safety. Variations in HLA class II genes have been suggested to predispose to anti-drug antibody formation (ADA), but characterisation of biolog
Autor:
I. Jyssum, A. T. Tveter, J. Sexton, I. E. Christensen, T. T. Tran, S. Mjaaland, D. J. Warren, T. K. Kvien, K. H. Bjørlykke, G. B. Kro, J. Jahnsen, L. A. Munthe, E. A. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, S. Aarrestad Provan, K. K. Jørgensen, G. L. Goll, S. W. Syversen
Publikováno v:
Annals of the Rheumatic Diseases. 81:127.1-128
BackgroundPatients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy have an inadequate serologic response following two-dose SARS-CoV-2 vaccination, and a standard vaccination strategy of three doses for this patient gr
BACKGROUND: Inconsistent associations between long-term exposure to particles with an aerodynamic diameter ≤2:5 lm [fine particulate matter (PM2:5)] components and mortality have been reported, partly related to challenges in exposure assessment. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::5af900ab6b685ea08d6d46439a355ea5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057460
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057460